Jeffrey H. Cooper

2010 - BioMarin Pharmaceutical

In 2010, Jeffrey H. Cooper earned a total compensation of $1.4M as Senior Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 29% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$121,083
Option Awards$707,490
Salary$357,700
Stock Awards$180,684
Other$8,872
Total$1,375,829

Cooper received $707.5K in option awards, accounting for 51% of the total pay in 2010.

Cooper also received $121.1K in non-equity incentive plan, $357.7K in salary, $180.7K in stock awards and $8.9K in other compensation.

Rankings

In 2010, Jeffrey H. Cooper's compensation ranked 4,240th out of 10,439 executives tracked by ExecPay. In other words, Cooper earned more than 59.4% of executives.

ClassificationRankingPercentile
All
4,240
out of 10,439
59th
Division
Manufacturing
1,502
out of 3,838
61st
Major group
Chemicals And Allied Products
296
out of 921
68th
Industry group
Drugs
161
out of 680
76th
Industry
Pharmaceutical Preparations
127
out of 481
74th
Source: SEC filing on March 23, 2012.

Cooper's colleagues

We found four more compensation records of executives who worked with Jeffrey H. Cooper at BioMarin Pharmaceutical in 2010.

2010

Jean-Jacques Bienaim

BioMarin Pharmaceutical

Chief Executive Officer

2010

Henry Fuchs

BioMarin Pharmaceutical

Chief Medical Officer

2010

Stephen Aselage

BioMarin Pharmaceutical

Executive Vice President & Chief Business Officer

2010

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

In-depth

You may also like